fda warning letters compounded semaglutide telehealth 2025 Troubling Findings in Study of GLP-1 Compounders FDA Targets GLP-1 and Peptide

If you're trying to boost GLP-1 naturally, a high-sugar breakfast may not keep you satisfied for long

Well create a personalized plan that blends medical weight loss , CoolSculpting , and nutritional support for a beautiful, healthy, and confident new you

These additional causes include sporadic genetic disorders, such as spinocerebellar atrophy type 27B, caused by GAA expansion in the FGF14 gene, and cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS), caused by biallelic expansions in the RFC1 gene

The presence of funnel plot asymmetry also suggests potential publication bias, which warrants further scrutiny